Determination of l-methamphetamine: A case history

Journal of Analytical Toxicology

Volumn 29, Issue 7, 2005, Pages 759-761

  Wyman, John F ^a   Cody, John T ^b  

^a Franklin County Coroner's Office   (United States)

^b AIR FORCE RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AMPHETAMINE; AZITHROMYCIN; CEFTRIAXONE; CHLORIDE; DEXAMETHASONE; DILTIAZEM; ENOXAPARIN; FAMOTIDINE; FUROSEMIDE; GLYCERYL TRINITRATE; IPRATROPIUM BROMIDE; LEVALBUTEROL; METHAMPHETAMINE; MIDAZOLAM; SALBUTAMOL; TRIFLUOROACETYLPROLYL CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; ASTHMA; BLOOD ANALYSIS; BREATHING DISORDER; CASE REPORT; CONGESTIVE HEART FAILURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG INTOXICATION; DRUG URINE LEVEL; ENANTIOMER; HUMAN; MALE; SEPARATION TECHNIQUE; URINALYSIS; VICKS;

EID: 29144437789     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/29.7.759     Document Type: Article

References (16)

1. R.L. Fitzgerald, J.M. Ramos, S.C. Bogema, and A. Poklis. Resolution of methamphetamine stereoisomers in urine drug testing: urinary excretion of (-)-methampthetamine following use of nasal inhalers. J. Anal. Toxicol 12: 255-259 (1988).
2. J.T. Cody and F. Schwarzhoff. Interpretation of methamphetamine and amphetamine enantiomer data. J. Anal. Toxicol. 17: 321-326 (1993).
3. D. Hensley and J.T. Cody. Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS. J. Anal. Toxicol. 23: 518-523 (1999).
4. T.S. Nagai, S. Kamiyama, A. Kurosu, and F. Iwamoto. Identification of optical isomers of methamphetamine and its application to forensic medicine. Nippon Hoigaku Zasshi 46(4): 244-253 (1992).
5. Therapeutic and abused drugs in serum, plasma or whole blood for GC or GC/MS confirmations using: 200 mg Clean Screen® extraction column. Procedure code: DRB200DAUZ050191. In Clean Screen Extraction Column Applications Manual. Worldwide Monitoring Corporation, Bristol, PA, 2002, p 11.
6. M.D. Solomon and J.A. Wright. False-positive for (+)-methamphetamine. Clin. Chem. 23(8): 1504 (1977).
7. A. Poklis, S.A. Jortani, C.S. Brown, and C.R. Crooks. Response of the Emit II amphetamine/methamphetamine assay to specimens collected following use of Vicks Inhalers. J. Anal. Toxicol. 17: 284-286 (1993).
8. H. Ando, H. Shimizu, Y. Takahashi, M. Fukumoto, H. Okonogi, and M. Kadokura. A basic study for estimating the level of exposure to nasal inhalant containing a stimulant. Nippon Eiseigaku Zasshi. 48(3): 692-697 (1993).
9. A. Poklis and K.A. Moore. Response of EMIT amphetamine immunoassays to urinary desoxyephedrine following Vicks inhaler use. Ther. Drug. Monit. 17(1): 89-94 (1995).
10. J.T. Cody. Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results. J. Occup. Environ. Med. 44(5): 435-450 (2002).
11. Substance Abuse and Mental Health Service Administration, Department of Health and Human Services. Mandatory guidelines for federal workplace drug testing programs. Fed. Regist. 69(71): 26-27 (2004). (http://www. drugfreeworkplace.gov/fedprograms/MandatoryGuidelines/MG04132004.htm).
12. R.W. Romberg, S.B. Needleman, J.J. Snyder, and A. Greedan. Methamphetamine and amphetamine derived from the metabolism of selegiline. J. Forensic Sci. 40(6): 1100-1102 (1995).
13. M.H. Slawson, J.L.Taccogno, R.L. Foltz, and D.E. Moody. Quantitative analysis of selegiline and three metabolites (N-desmethylselegiline, methamphetamine, and amphetamine) in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. J. Anal. Toxicol. 26: 430-437 (2002).
14. R. Kronstrand, J. Ahlner, N. Dizdar, and G. Larson. Quantitative analysis of desmethylselegiline, methamphetamine, and amphetamine in hair and plasma from Parkinson patients on longterm selegiline medication. J. Anal. Toxicol. 27: 135-141 (2003).
15. B. Greenhill. Metabolic profile of amphetamine and methamphetamine following administration of the drug famprofazone. J. Anal. Toxicol. 27: 479-484 (2003).
16. A. Rodriguez, S. Valtier, and J.T. Cody. Metabolic profile of famprofazone following multidose administration. J. Anal. Toxicol. 28: 432-438 (2004).